LLGL1 and acute myeloid leukemia: To validate the functional impact of LLGL1 deletion in human AML cells in vivo, we performed RNAi-mediated deletion of LLGL1 in MOLM-13 cells and assessed for disease dynamics after transplantation into humanized NSGS mice (Fig. 1E, F, Supplementary Fig. 1D).